HIV prevalence and related risk behaviours among prisoners in Iran: Results of the national biobehavioural survey, 2009

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 3, 2013, Pages

  Navadeh, Soodabeh ^a   Mirzazadeh, Ali ^a,b   Gouya, Mohammad Mehdi ^c   Farnia, Marziyeh ^d   Alasvand, Ramin ^d   Haghdoost, Ali Akbar ^a,e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d Iran Prison Organization   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CONDOM USE; DRUG ADMINISTRATION; EXTRAMARITAL SEXUAL INTERCOURSE; FEMALE; HEALTH SURVEY; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IRAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRISONER; SEXUALLY TRANSMITTED DISEASE; TATTOOING; YOUNG ADULT;

AIDS; DRUG MISUSE; HIV;

ADULT; AGE DISTRIBUTION; ANALGESICS, OPIOID; CONDOMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HARM REDUCTION; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; IRAN; MALE; METHADONE; MIDDLE AGED; ODDS RATIO; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; PRISONERS; PRISONS; QUESTIONNAIRES; RISK ASSESSMENT; RISK-TAKING; SENTINEL SURVEILLANCE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; TATTOOING;

EID: 84891888743     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051295     Document Type: Article

References (13)

1. Dolan K, Kite B, Black E, et al. HIV in prison in low-income and middle-income countries. Lancet Infect Dis 2007;7:32-41.
2. Shahbazi M, Farnia M, Moradi G, et al. The trend of HIV/AIDS prevalence among IDU's in Iranian prisoners (1376-1386) [abstract]. Retrovirology 2010;7(Suppl 1):P101.
3. Farnia M, Ebrahimi B, Shams A, et al. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Int J Drug Policy 2010;21:422-4.
4. Zamani S, Farnia M, Torknejad A, et al. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 2010;87:603-16.
5. Haghdoost A, Mostafavi E, Mirzazadeh A, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res 2011;3:231-9.
6. Azarkar Z, Sharifzadeh G, Miraki M. HBV, HCV and HIV prevalence among south Khorasan prisoners. J Birjand Univ Med Sci 2007;2:50-5. (Abstract in English, full text in Persian).
7. Javadi A, Ataei B, Pourahmad M. The relationship between frequency and duration of imprisonment and the prevalence of HBS Ag, AntiHCV and HIV antibody seropositivity in Iranian prisoners. J Med Council IRI 2007;24:358-64.
8. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost A, et al. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy 2012;23:271-8.
9. Amon J, Brown T, Hogle J, et al. Behavioral surveillance surveys BSS; guidelines for repeated behavioral surveys in populations at risk of HIV. Washington DC: Family Health International, 2009.
10. UNIADS Monitoring the Declaration of Commitment on HIV/AIDS. Guidelines on construction of core indicators: 2010 reporting, United Nations General Assembly Special Session on HIV/AIDS. Geneva, Switzerland: UNAIDS, 2009.
11. Butler T, Boonwaat L, Hailstone S, et al. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Aust N Z Public Health 2007;31: 44-50.
12. Nasirian M, Doroudi F, Gooya MM, et al. Modeling of human immunodeficiency virus modes of transmission in iran. J Res Health Sci 2012;12:81-7.
13. Mirzazadeh A, Haghdoost AA, Nedjat S, et al. Accuracy of HIV-related risk behaviors reported by female sex workers, Iran: a method to quantify measurement bias in marginalized populations. AIDS Behav 2013;17:623-31.